Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Scott H. Davis who wrote (8345)	3/3/1998 2:29:00 PM
From: Ron Luhmann	Read Replies (1) \| Respond to of 14328

FDA approval for Unigold-HIV is significant in the approval of TRIBY'd Unigold technology...and the subsequent submission of the rest of their Unigold products in the U.S....just look at the cover of the most recent U.S. News & World Report...its all about HMO's cutting costs to stay profitable...That's EXACTLY Triby's strongpoint!!! Kaiser Permantnete lost $270 Mil in '97 despite increasing membership by 19%... Oxford Health lost $200 Mil 4th qtr...and a 60% drop in share price..Triby's products are just what the HMO's need to stay in the black...reduce lab costs and repeated Dr. visits for the results of the lab work...our STUBBORN Irishmen are on the right track but need to keep their shareholders regularly informed...not to tip their hand or tell their business plan...stop kicking to dog that gets the paper for you.... GO TRIBY ! Rah!..... :-) Ron